triamcinolone acetonide has been researched along with Syndrome, VKH (Vogt Koyanagi Harada) in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 3 (37.50) | 2.80 |
| Authors | Studies |
|---|---|
| Ando, Y; Hayashi, I; Keino, H; Nakayama, M; Okada, AA; Watanabe, T | 1 |
| Elsayed, MA; Tabl, AA; Tabl, MA | 1 |
| Mito, T; Sayama, K; Shiraishi, K; Yoshida, S | 1 |
| Hayashi, H; Hosoda, Y; Kuriyama, S | 1 |
| Dong, F; Gao, F; Zhang, M; Zhao, C | 1 |
| Andrade, RE; Belfort, R; Farah, ME; Muccioli, C; Nussenblatt, RB | 1 |
| Cakir, H; Kaya, V; Perente, I; Tutkun, IT; Utine, CA; Yilmaz, OF | 1 |
| Johnston, CA; Teitelbaum, CS | 1 |
8 other study(ies) available for triamcinolone acetonide and Syndrome, VKH (Vogt Koyanagi Harada)
| Article | Year |
|---|---|
A COVID-19 Risk Reduction Strategy for the Treatment of Acute Vogt-Koyanagi-Harada Disease Utilizing the Antiviral Potential of Cyclosporine.
Topics: Aged; COVID-19; Cyclosporine; Glucocorticoids; Humans; Pandemics; Retrospective Studies; Triamcinolone Acetonide; Uveomeningoencephalitic Syndrome | 2023 |
Suprachoroidal triamcinolone acetonide injection: a novel therapy for serous retinal detachment due to Vogt-Koyanagi Harada disease.
Topics: Humans; Prospective Studies; Retinal Detachment; Triamcinolone Acetonide; Uveomeningoencephalitic Syndrome; Visual Acuity | 2022 |
Vogt-Koyanagi-Harada-like syndrome induced by immune checkpoint inhibitors in a patient with melanoma.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; Humans; Immune Checkpoint Inhibitors; Ipilimumab; Male; Melanoma; Middle Aged; Triamcinolone Acetonide; Uveomeningoencephalitic Syndrome; Vitiligo | 2020 |
Posterior subtenon triamcinolone acetonide injection as a primary treatment in eyes with acute Vogt-Koyanagi-Harada disease.
Topics: Adult; Anti-Inflammatory Agents; Cross-Sectional Studies; Drug Administration Routes; Female; Fluorescein Angiography; Humans; Male; Middle Aged; Recurrence; Retrospective Studies; Tomography, Optical Coherence; Triamcinolone Acetonide; Uveomeningoencephalitic Syndrome; Visual Acuity | 2015 |
Surgical Treatment of Subretinal Fibrosis Caused Macular Detachment in Vogt-Koyanagi-Harada Disease: A Pioneer Study.
Topics: Adult; Endotamponade; Female; Fibrosis; Fluorocarbons; Glucocorticoids; Humans; Male; Middle Aged; Ophthalmologic Surgical Procedures; Retina; Retinal Detachment; Retrospective Studies; Silicone Oils; Triamcinolone Acetonide; Uveomeningoencephalitic Syndrome; Visual Acuity; Young Adult | 2018 |
Intravitreal triamcinolone in the treatment of serous retinal detachment in Vogt-Koyanagi-Harada syndrome.
Topics: Acute Disease; Female; Glucocorticoids; Humans; Injections; Intraocular Pressure; Middle Aged; Prospective Studies; Retinal Detachment; Tomography, Optical Coherence; Triamcinolone Acetonide; Uveomeningoencephalitic Syndrome; Visual Acuity; Vitreous Body | 2004 |
Management of ocular complications of Vogt-Koyanagi-Harada syndrome.
Topics: Adolescent; Cyclosporine; Drug Therapy, Combination; Eye Diseases; Female; Fluorescein Angiography; Glucocorticoids; Humans; Immunosuppressive Agents; Optic Nerve Diseases; Retinal Detachment; Tomography, Optical Coherence; Triamcinolone Acetonide; Ultrasonography; Uveomeningoencephalitic Syndrome; Vitreous Body | 2009 |
Magnetic resonance imaging in Vogt-Koyanagi-Harada syndrome.
Topics: Administration, Oral; Adult; Chlorambucil; Diagnosis, Differential; Female; Humans; Magnetic Resonance Imaging; Prednisone; Tomography, X-Ray Computed; Triamcinolone Acetonide; Uveitis; Uveomeningoencephalitic Syndrome | 1990 |